Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2003
06/24/2003US6583153 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
06/24/2003US6583150 Cytotoxic propertie; antitumor; pyrido-(3,2-g)quinoline-5,10-diones; benzo(b)pyrido(4,3,2-de)(1,7)-phenanthroline-8-ones
06/24/2003US6583145 Thio-oxindole derivatives
06/24/2003US6583141 T cell mediated rheumatic diseases
06/24/2003US6583126 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
06/24/2003US6583122 Use in boron neutron capture therapy (BNCT) and diagnostic purposes; treating cancer, viral infections such as HIV, hepatitis B virus
06/24/2003US6583108 Human bikunin
06/24/2003US6582947 Nucleotide sequences coding enzymatic polypeptide for use in the virus treatment of cancer and viral infection
06/24/2003US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof
06/24/2003US6582918 Platelet derived growth factor (PDGF) nucleic acid ligand complexes
06/24/2003US6582747 Dry cocoa mix containing a mixture of non-alkalized and alkalized cocoa solids
06/24/2003US6582690 Process for treating tumors with cytotoxic substances
06/24/2003US6582689 Interferon- gamma -inducing factor (IGIF), in combination with a chemotherapeutic agent, processes for making such compositions, the use of such compositions for the prevention and/or treatment of cancer, and the use of such compositions
06/24/2003US6581607 Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/24/2003CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/24/2003CA2087251C Pharmaceutical compositions
06/24/2003CA2012311C New protein-polycation-conjugate
06/19/2003WO2003050502A2 Prospective identification and characterization of breast cancer stem cells
06/19/2003WO2003050499A2 Use of a labeled ligand having human cd4 specificity
06/19/2003WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003WO2003050271A2 In vitro production of dendritic cells from cd14+ monocytes
06/19/2003WO2003050267A2 Method of isolating extract from the euphorbaciae obesa plant and methods for using the same
06/19/2003WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003WO2003050254A2 Novel chimeric tnf ligands
06/19/2003WO2003050252A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003WO2003050251A2 Hematopoietic cells from human embryonic stem cells
06/19/2003WO2003050236A2 Human genes and gene expression products isolated from human prostate
06/19/2003WO2003050140A1 Tumor antigens
06/19/2003WO2003050129A1 Use of phosphonate nucleotide analogue for treating hepatitis b virus infections
06/19/2003WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
06/19/2003WO2003050122A2 Mitotic kinesin inhibitors
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003050093A1 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer
06/19/2003WO2003050091A1 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
06/19/2003WO2003050090A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003WO2003050072A1 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003050064A2 Mitotic kinesin inhibitors
06/19/2003WO2003049804A2 Treatment of genitourinary tract disorders
06/19/2003WO2003049774A1 Transdermal transport of compounds
06/19/2003WO2003049772A2 Guanidinium transport reagents and conjugates
06/19/2003WO2003049760A1 Compositions and method for treating hepatitis virus infection
06/19/2003WO2003049752A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
06/19/2003WO2003049743A1 Combination cancer therapy
06/19/2003WO2003049740A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049738A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
06/19/2003WO2003049734A1 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
06/19/2003WO2003049731A1 Process for affecting neurologic progression
06/19/2003WO2003049728A1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation
06/19/2003WO2003049727A1 Treatment of neoplasia
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049717A2 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases
06/19/2003WO2003049697A2 Treatment of glioblastoma with thymosin-alpha 1
06/19/2003WO2003049694A2 Methods of therapy for non-hodgkin's lymphoma
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003049678A2 Mitotic kinesin inhibitors
06/19/2003WO2003049675A2 Treating muscle wasting with selective androgen receptor modulators
06/19/2003WO2003049667A2 The method of treating cancer
06/19/2003WO2003049527A2 Mitotic kinesin inhibitors
06/19/2003WO2003020252A3 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
06/19/2003WO2003009777A3 Delivery of therapeutic capable agents
06/19/2003WO2003007882A3 Method of making bowman-birk inhibitor product
06/19/2003WO2003007798A3 Ophthalmic use of 5 fluorourcil
06/19/2003WO2002094864A3 Human cdnas and proteins and uses thereof
06/19/2003WO2002088172B1 Pentapeptide compounds and uses related thereto
06/19/2003WO2002060434A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
06/19/2003WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003WO2002004664A3 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells
06/19/2003WO2002004514A3 Compositions and methods for the therapy and diagnosis of lung cancer
06/19/2003WO2001068076A8 D-enantiomer of dfmo and methods of use thereof for treating cancer
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114672 Purine inhibitors of protein kinases, G proteins and polymerases
06/19/2003US20030114516 Novel immunotherapeutic agents
06/19/2003US20030114513 Use of isatin derivatives as ion channel activating agents
06/19/2003US20030114511 Antitumor agents, a glyoxylamide compounds, drug resistance and metastasizing carcinoma, angiogenesis inhibitors, side effect reduction, nontoxic
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114505 Novel isoxazole and thiazole compounds and use thereof as drugs
06/19/2003US20030114504 Compositions and methods for the treatment of cancer
06/19/2003US20030114493 Antitumor agents
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114477 Rapamycin 29-Enols
06/19/2003US20030114473 Anticancer agents
06/19/2003US20030114471 Anticancer agent
06/19/2003US20030114467 Novel pyrazolo- and pyrrolo-pyrimidines and uses thereof
06/19/2003US20030114460 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114455 Sexual disorders
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114442 Reducing concentration of blood lipoproteins
06/19/2003US20030114434 Extended duration light activated cancer therapy
1 ... 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 ... 2211